1. Home
  2. SNGX vs BTTC Comparison

SNGX vs BTTC Comparison

Compare SNGX & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.37

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

BTTC

Black Titan Corporation Ordinary Shares

HOLD

Current Price

$0.37

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
BTTC
Founded
1987
1990
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
8.3M
IPO Year
2006
2024

Fundamental Metrics

Financial Performance
Metric
SNGX
BTTC
Price
$0.37
$0.37
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
205.9K
710.1K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.22
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.38
52 Week High
$2.98
$11.22

Technical Indicators

Market Signals
Indicator
SNGX
BTTC
Relative Strength Index (RSI) 40.30 22.63
Support Level $0.36 N/A
Resistance Level $0.42 $0.85
Average True Range (ATR) 0.02 0.03
MACD -0.00 -0.00
Stochastic Oscillator 7.46 4.01

Price Performance

Historical Comparison
SNGX
BTTC

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About BTTC Black Titan Corporation Ordinary Shares

Black Titan Corp provides human resource and payroll consulting, software implementation, and training solutions using PeopleSoft platforms. The company's revenue is mainly derived from the provision of HCM solutions, followed by the provision of IT staff augmentation, outsourcing and consulting services.

Share on Social Networks: